News

Houda Alachkar of the USC School of Pharmacy was awarded a five-year, $1.79 million National Institutes of Health (NIH) grant to fund a study that could lead to advancements in the development of personalized treatments for acute myeloid leukemia
Humanity has never seen a global research collaboration on this scale — but USC experts including Frances Richmond of the USC School of Pharmacy note that the vaccine development and approval process remains a long and laborious one.
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.